• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Med (Lausanne) . Systematic Review and Meta-Analysis of Sex-Specific COVID-19 Clinical Outcomes

tetano

Editor, Senior Moderator
Front Med (Lausanne)


. 2020 Jun 23;7:348.
doi: 10.3389/fmed.2020.00348. eCollection 2020.
Systematic Review and Meta-Analysis of Sex-Specific COVID-19 Clinical Outcomes


Thushara Galbadage[SUP] 1 [/SUP], Brent M Peterson[SUP] 1 [/SUP], Joseph Awada[SUP] 2 [/SUP], Alison S Buck[SUP] 2 [/SUP], Danny A Ramirez[SUP] 2 [/SUP], Jason Wilson[SUP] 3 [/SUP], Richard S Gunasekera[SUP] 2 [/SUP]



Affiliations

Abstract

To successfully mitigate the extraordinary devastation caused by the Coronavirus disease 2019 (COVID-19) pandemic, it is crucial to identify important risk factors for this disease. One such neglected health determinant is the sex of the patient. This is an essential clinical characteristic, as it can factor into a patient's clinical management and preventative measures. Some clinical studies have shown disparities in the proportion between males and females that have more severe clinical outcomes or, subsequently, die from this disease. However, this association has not been unequivocally established. Thus, the purpose of this investigation was to examine the association between male sex and COVID-19 severity. We systematically reviewed the literature, identified studies that matched predetermined selection criteria, and performed a meta-analysis to evaluate the proportion of males among four disease severity categories. Appropriate assessment strategies were implemented to assess and minimize potential biases. The results of this meta-analysis indicated that males constituted a significantly higher proportion of those who had adverse clinical outcomes and died from COVID-19. As the coronavirus spread from the East to the West, male sex remained a consistent risk factor. Our results support the establishment of the male sex as an important risk factor for this disease. Early identification and appropriate medical care for males with lab-confirmed COVID-19 may substantially change the course of clinical prognosis, resulting in greater numbers of lives saved.

Keywords: COVID-19; SARS-CoV-2; clinical outcomes; coronavirus; disparity; male; mortality; pandemic.
 
Back
Top Bottom